{"entity":{"type":"insider","cik":"0001697422","url":"/insider/0001697422","json_url":"/insider/0001697422.json","name":"Fenimore Christopher R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":84,"n_filings":13,"first":"2018-12-20","last":"2024-08-29","span_basis":"filed_date"},"name_variants":[{"name":"Fenimore Christopher R.","source":"filing","n_filings":13,"first_seen":"2018-12-20","last_seen":"2024-08-29"}],"transactions":[{"id":3102963,"accession":"0001883850-24-000045","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001883850-24-000045","line_url":"/filing/0001883850-24-000045","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Finance & CFO)","role_mark":"O","role_mark_label":"Officer (SVP Finance & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Finance & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5680.0,"shares_display":"5,680","price_per_share":1205.3278556338028,"price_display":"1,205.33","price_state":"stated","total_value":6846262.22,"total_display":"6,846,262.22","total_whole":"6,846,262","shares_owned_after":1378.0,"shares_owned_after_display":"1,378","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-08-29","scope":"insider","n_lines":10},{"id":2977483,"accession":"0001968202-24-000061","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001968202-24-000061","line_url":"/filing/0001968202-24-000061","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Finance & CFO)","role_mark":"O","role_mark_label":"Officer (SVP Finance & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Finance & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4919.0,"shares_display":"4,919","price_per_share":953.307532018703,"price_display":"953.31","price_state":"stated","total_value":4689319.75,"total_display":"4,689,319.75","total_whole":"4,689,320","shares_owned_after":16072.0,"shares_owned_after_display":"16,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-09","filed_date":"2024-02-12","scope":"insider","n_lines":6},{"id":8271888,"accession":"0001883850-23-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001883850-23-000107","line_url":"/filing/0001883850-23-000107#line-1","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Controller)","role_mark":"O","role_mark_label":"Officer (SVP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2448.0,"shares_display":"2,448","price_per_share":856.71,"price_display":"856.71","price_state":"stated","total_value":2097226.08,"total_display":"2,097,226.08","total_whole":"2,097,226","shares_owned_after":14372.0,"shares_owned_after_display":"14,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":8212658,"accession":"0001883850-23-000103","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001883850-23-000103","line_url":"/filing/0001883850-23-000103#line-3","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Controller)","role_mark":"O","role_mark_label":"Officer (SVP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":846.27,"price_display":"846.27","price_state":"stated","total_value":211567.5,"total_display":"211,567.50","total_whole":"211,568","shares_owned_after":16820.0,"shares_owned_after_display":"16,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-26","scope":"insider"},{"id":8212657,"accession":"0001883850-23-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001883850-23-000103","line_url":"/filing/0001883850-23-000103","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Controller)","role_mark":"O","role_mark_label":"Officer (SVP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1680.0,"shares_display":"1,680","price_per_share":844.0085714285714,"price_display":"844.01","price_state":"stated","total_value":1417934.4,"total_display":"1,417,934.40","total_whole":"1,417,934","shares_owned_after":17070.0,"shares_owned_after_display":"17,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-26","scope":"insider","n_lines":2},{"id":8718391,"accession":"0001883850-23-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001883850-23-000060","line_url":"/filing/0001883850-23-000060#line-1","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Controller)","role_mark":"O","role_mark_label":"Officer (SVP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2192.0,"shares_display":"2,192","price_per_share":806.47,"price_display":"806.47","price_state":"stated","total_value":1767782.24,"total_display":"1,767,782.24","total_whole":"1,767,782","shares_owned_after":18409.0,"shares_owned_after_display":"18,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-27","scope":"insider"},{"id":6689685,"accession":"0001883850-22-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001883850-22-000080","line_url":"/filing/0001883850-22-000080#line-1","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Controller)","role_mark":"O","role_mark_label":"Officer (SVP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1844.0,"shares_display":"1,844","price_per_share":749.0,"price_display":"749.00","price_state":"stated","total_value":1381156.0,"total_display":"1,381,156.00","total_whole":"1,381,156","shares_owned_after":16425.0,"shares_owned_after_display":"16,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-07","scope":"insider"},{"id":6910870,"accession":"0001883850-22-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001883850-22-000077","line_url":"/filing/0001883850-22-000077#line-1","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Controller)","role_mark":"O","role_mark_label":"Officer (SVP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3346.0,"shares_display":"3,346","price_per_share":724.0,"price_display":"724.00","price_state":"stated","total_value":2422504.0,"total_display":"2,422,504.00","total_whole":"2,422,504","shares_owned_after":18269.0,"shares_owned_after_display":"18,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":5124718,"accession":"0001237899-21-000017","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001237899-21-000017","line_url":"/filing/0001237899-21-000017","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (SVP Controller)","role_mark":"O","role_mark_label":"Officer (SVP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4781.0,"shares_display":"4,781","price_per_share":655.3099979083873,"price_display":"655.31","price_state":"stated","total_value":3133037.1,"total_display":"3,133,037.10","total_whole":"3,133,037","shares_owned_after":27944.0,"shares_owned_after_display":"27,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider","n_lines":7},{"id":2488683,"accession":"0001237899-20-000035","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001237899-20-000035","line_url":"/filing/0001237899-20-000035","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3709.0,"shares_display":"3,709","price_per_share":642.0374629280129,"price_display":"642.04","price_state":"stated","total_value":2381316.95,"total_display":"2,381,316.95","total_whole":"2,381,317","shares_owned_after":19491.0,"shares_owned_after_display":"19,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-22","scope":"insider","n_lines":13},{"id":2934760,"accession":"0001708138-20-000074","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001708138-20-000074","line_url":"/filing/0001708138-20-000074#line-18","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":747.0,"shares_display":"747","price_per_share":594.35,"price_display":"594.35","price_state":"stated","total_value":443979.45,"total_display":"443,979.45","total_whole":"443,979","shares_owned_after":15974.0,"shares_owned_after_display":"15,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":2934750,"accession":"0001708138-20-000074","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001708138-20-000074","line_url":"/filing/0001708138-20-000074#line-17","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":413.0,"shares_display":"413","price_per_share":586.54,"price_display":"586.54","price_state":"stated","total_value":242241.02,"total_display":"242,241.02","total_whole":"242,241","shares_owned_after":17950.0,"shares_owned_after_display":"17,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":2934745,"accession":"0001708138-20-000074","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001708138-20-000074","line_url":"/filing/0001708138-20-000074#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":403.0,"shares_display":"403","price_per_share":595.5,"price_display":"595.50","price_state":"stated","total_value":239986.5,"total_display":"239,986.50","total_whole":"239,987","shares_owned_after":15571.0,"shares_owned_after_display":"15,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":2934741,"accession":"0001708138-20-000074","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001708138-20-000074","line_url":"/filing/0001708138-20-000074#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":373.0,"shares_display":"373","price_per_share":587.55,"price_display":"587.55","price_state":"stated","total_value":219156.15,"total_display":"219,156.15","total_whole":"219,156","shares_owned_after":17577.0,"shares_owned_after_display":"17,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":2934735,"accession":"0001708138-20-000074","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001708138-20-000074","line_url":"/filing/0001708138-20-000074#line-14","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":596.36,"price_display":"596.36","price_state":"stated","total_value":175329.84,"total_display":"175,329.84","total_whole":"175,330","shares_owned_after":15277.0,"shares_owned_after_display":"15,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":2934729,"accession":"0001708138-20-000074","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001708138-20-000074","line_url":"/filing/0001708138-20-000074#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":591.61,"price_display":"591.61","price_state":"stated","total_value":137845.13,"total_display":"137,845.13","total_whole":"137,845","shares_owned_after":17044.0,"shares_owned_after_display":"17,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"},{"id":2934725,"accession":"0001708138-20-000074","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001708138-20-000074","line_url":"/filing/0001708138-20-000074#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001697422","owner_name":"Fenimore Christopher R.","owner_display_name":"Fenimore Christopher R.","owner_url":"/insider/0001697422","role":"Officer (VP Controller)","role_mark":"O","role_mark_label":"Officer (VP Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214.0,"shares_display":"214","price_per_share":592.2,"price_display":"592.20","price_state":"stated","total_value":126730.8,"total_display":"126,730.80","total_whole":"126,731","shares_owned_after":16830.0,"shares_owned_after_display":"16,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-17","scope":"insider"}],"collapsed":true,"next_cursor":"2020-06-16|2934725","ledger_fault":false,"count":{"value":84,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":84,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":84},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS, INC.","url":"/issuer/0000872589","role":"Officer (SVP Finance & CFO)","n_filings":13,"first_seen":"2018-12-20","last_seen":"2024-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001697422","retrieved_at":"2026-08-27T03:46:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}